Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Proprietary compound preparation BNF 0503010
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Triumeq 50mg/600mg/300mg tablets
050301000BBADA0
|
Proprietary compound preparation BNF 0503010 | Other HIV infection preparations | Infections | 6 |
|
Genvoya 150mg/150mg/200mg/10mg tablets
050301000BBAEA0
|
Proprietary compound preparation BNF 0503010 | Other HIV infection preparations | Infections | 3 |
|
Symtuza 800mg/150mg/200mg/10mg tablets
050301000BBAGA0
|
Proprietary compound preparation BNF 0503010 | Other HIV infection preparations | Infections | 2 |
|
Odefsey 200mg/25mg/25mg tablets
050301000BBAFA0
|
Proprietary compound preparation BNF 0503010 | Other HIV infection preparations | Infections | 1 |
|
Stribild 150mg/150mg/200mg/245mg tablets
050301000BBACA0
|
Proprietary compound preparation BNF 0503010 | Other HIV infection preparations | Infections | 1 |
|
Eviplera 200mg/25mg/245mg tablets
050301000BBABA0
|
Proprietary compound preparation BNF 0503010 | Other HIV infection preparations | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.